Halozyme Therapeutics, Inc. (HALO)

67.37 +0.01 (+0.01%) USD  |  NASDAQ  |  Mar 06, 16:00
67.98 +0.61 (+0.91%) After-Hours: 20:00
More

Halozyme Therapeutics Domestic Sales (5 Year Growth)

Domestic Sales (5 Year Growth) Chart

View Domestic Sales (5 Year Growth) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Domestic Sales (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Domestic Sales (5 Year Growth) Range, Past 5 Years

View Domestic Sales (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Domestic Sales (5 Year Growth) Benchmarks

View Domestic Sales (5 Year Growth) Benchmarks
Start Trial
Johnson & Johnson --
Skye Bioscience, Inc. --
AIM ImmunoTech, Inc. --
Stryker Corp. --
Glaukos Corp. --